99 related articles for article (PubMed ID: 33761040)
1. An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution.
Iudicello A; Genovese F; Di Iorio V; Cicoria G; Boschi S
EJNMMI Radiopharm Chem; 2021 Mar; 6(1):14. PubMed ID: 33761040
[TBL] [Abstract][Full Text] [Related]
2. Automated radiolabelling of [
van Brandwijk EA; Aalbersberg EA; Hosseini AS; Huitema ADR; Hendrikx JJMA
EJNMMI Radiopharm Chem; 2024 Apr; 9(1):31. PubMed ID: 38632189
[TBL] [Abstract][Full Text] [Related]
3. A Specific HPLC Method to Determine Residual HEPES in [
Migliari S; Scarlattei M; Baldari G; Silva C; Ruffini L
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889351
[TBL] [Abstract][Full Text] [Related]
4. "One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617.
Fouillet J; Donzé C; Deshayes E; Santoro L; Rubira L; Fersing C
Curr Radiopharm; 2024 Feb; ():. PubMed ID: 38424422
[TBL] [Abstract][Full Text] [Related]
5. Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.
Thisgaard H; Kumlin J; Langkjær N; Chua J; Hook B; Jensen M; Kassaian A; Zeisler S; Borjian S; Cross M; Schaffer P; Dam JH
EJNMMI Radiopharm Chem; 2021 Jan; 6(1):1. PubMed ID: 33411034
[TBL] [Abstract][Full Text] [Related]
6. Validation of a [Al
Al-Momani E; Israel I; Samnick S
Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [
Migliari S; Sammartano A; Scarlattei M; Serreli G; Ghetti C; Cidda C; Baldari G; Ortenzia O; Ruffini L
ACS Omega; 2017 Oct; 2(10):7120-7126. PubMed ID: 29520394
[No Abstract] [Full Text] [Related]
8.
Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.
Iudicello A; Boschi S; Ghedini P; Lohr F; Panareo S
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337140
[TBL] [Abstract][Full Text] [Related]
11. Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.
Tsionou MI; Knapp CE; Foley CA; Munteanu CR; Cakebread A; Imberti C; Eykyn TR; Young JD; Paterson BM; Blower PJ; Ma MT
RSC Adv; 2017 Oct; 7(78):49586-49599. PubMed ID: 29308192
[TBL] [Abstract][Full Text] [Related]
12. Validation of HPLC method for the determination of chemical andradiochemical purity of a
UĞur A; ElÇİ ŞG; YÜksel D
Turk J Chem; 2021; 45(1):26-34. PubMed ID: 33679149
[TBL] [Abstract][Full Text] [Related]
13. (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
Gourni E; Canovas C; Goncalves V; Denat F; Meyer PT; Maecke HR
PLoS One; 2015; 10(12):e0145755. PubMed ID: 26700033
[TBL] [Abstract][Full Text] [Related]
14. Preparation of
Wang Y; Shao G; Wu J; Cui C; Zang S; Qiu F; Jia R; Wang Z; Wang F
Contrast Media Mol Imaging; 2018; 2018():8046541. PubMed ID: 29853810
[TBL] [Abstract][Full Text] [Related]
15. Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro.
Malik N; Baur B; Winter G; Reske SN; Beer AJ; Solbach C
Mol Imaging Biol; 2015 Dec; 17(6):777-85. PubMed ID: 25869080
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of an Al
Giglio J; Zeni M; Savio E; Engler H
EJNMMI Radiopharm Chem; 2018; 3(1):4. PubMed ID: 29503861
[TBL] [Abstract][Full Text] [Related]
17. Radiochemistry and Preclinical PET Imaging of
Gourni E; Del Pozzo L; Bartholomä M; Kiefer Y; T Meyer P; Maecke HR; Holland JP
Mol Imaging; 2017; 16():1536012117737010. PubMed ID: 29098927
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector.
Läppchen T; Kiefer Y; Holland JP; Bartholomä MD
Nucl Med Biol; 2018 May; 60():45-54. PubMed ID: 29571066
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue.
Asti M; Iori M; Capponi PC; Atti G; Rubagotti S; Martin R; Brennauer A; Müller M; Bergmann R; Erba PA; Versari A
Nucl Med Biol; 2014 Jan; 41(1):24-35. PubMed ID: 24183610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
